EAM
MDCO

EverPoint Asset Management’s Medicines Co MDCO Stock Holding History

EverPoint Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-50,000
Closed -$1.89M – 579
2016
Q3 		$1.89M Buy
+50,000
New +$1.88M 0.03% 348

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

EverPoint Asset Management's MDCO Position: Q4 2016 in Review

EverPoint Asset Management sold out of Medicines Co (MDCO) in Q4 2016, closing a stake of 700,000 shares — an estimated $26.4M sold.

EverPoint Asset Management first reported a position in MDCO in Q4 2014 and held it in 6 quarters. The position peaked at $26.4M in Q3 2016. 195 funds tracked by Wall St. Rank hold MDCO as of Q4 2016.

  • EverPoint Asset Management reported no remaining Medicines Co position as of Q4 2016 after selling out during the quarter.
  • EverPoint Asset Management sold 700,000 Medicines Co shares in Q4 2016, an estimated $26.4M.
  • EverPoint Asset Management first reported a position in Medicines Co in Q4 2014 and held it in 6 quarters.
  • EverPoint Asset Management's Medicines Co position peaked at $26.4M in Q3 2016.
  • 195 funds tracked by Wall St. Rank held Medicines Co as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.